Predictive nomogram based on serum tumor markers and clinicopathological features for stratifying lymph node metastasis in breast cancer

BMC Cancer. 2022 Dec 19;22(1):1328. doi: 10.1186/s12885-022-10436-3.

Abstract

Background: This study was aimed to establish the nomogram to predict patients' axillary node status by using patients' clinicopathological and tumor characteristic factors.

Methods: A total of 705 patients with breast cancer were enrolled in this study. All patients were randomly divided into a training group and a validation group. Univariate and multivariate ordered logistic regression were used to determine the predictive ability of each variable. A nomogram was performed based on the factors selected from logistic regression results. Receiver operating characteristic curve (ROC) analysis, calibration plots and decision curve analysis (DCA) were used to evaluate the discriminative ability and accuracy of the models.

Results: Logistic regression analysis demonstrated that CEA, CA125, CA153, tumor size, vascular-invasion, calcification, and tumor grade were independent prognostic factors for positive ALNs. Integrating all the predictive factors, a nomogram was successfully developed and validated. The C-indexes of the nomogram for prediction of no ALN metastasis, positive ALN, and four and more ALN metastasis were 0.826, 0.706, and 0.855 in training group and 0.836, 0.731, and 0.897 in validation group. Furthermore, calibration plots and DCA demonstrated a satisfactory performance of our nomogram.

Conclusion: We successfully construct and validate the nomogram to predict patients' axillary node status by using patients' clinicopathological and tumor characteristic factors.

Keywords: Breast cancer; Clinicopathological features; Lymph node metastasis; Prognostic nomogram; Serum tumor markers.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Biomarkers, Tumor
  • Breast Neoplasms* / pathology
  • Female
  • Humans
  • Lymph Nodes / pathology
  • Lymphatic Metastasis* / pathology
  • Neoplasms, Second Primary* / pathology
  • Nomograms
  • Retrospective Studies

Substances

  • Biomarkers, Tumor